arrow
S

Stephen E. Fawell

AstraZeneca
H指数:48
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor

吡嗪羧酰胺AZ3246的发现与优化:一种选择性HPK1抑制剂

2025-02-102
PRE
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective Inhibitor
2024-12-100
PRE
First disclosure of AZD8421, a highly selective CDK2 inhibitor to address resistance to CDK4/6 inhibitors in breast and CCNE1-high cancers
2024-04-051
PRE
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
2023-03-134
OA
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper br
2022-08-0574
OAAI
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
2021-09-2781
PREAI
Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition
2021-03-3011
OA
AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib
2021-02-0516
OAAI
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
2021-01-2567
OAAI
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist
2020-09-1072
PREAI
Drug mechanism-of-action discovery through the integration of pharmacological andCRISPRscreens
2020-07-0659
OAAI
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors
2020-04-2923
OAAI
Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor

发现 (2R)-N-[3-[2-[(3-甲氧基-1-甲基-吡唑-4-基) 氨基] pyrimidin-4-yl]-1h-吲哚-7-基]-2-(4-甲基哌嗪-1-基) 丙烯酰胺 (AZD4205) 作为有效和选择性的Janus激酶1抑制剂

2020-04-1639
PREAI
EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

EED靶向的protac降解PRC2复合物中的EED,EZH2和SUZ12

2020-01-01153
OAAI
EED targeted PROTACs degrade EED, EZH2, and SUZ12 in the PRC2 complex
2019-12-010
PRE